ITOCHU Announces Capital and Business Alliance with iLAC, a Whole Genome Analysis Start-Up
(WorldNews Japan)

ITOCHU Corporation (headquartered in Minato-ku, Tokyo; Yoshihisa Suzuki, President & COO; hereinafter `ITOCHU`) announced today that it has formed a capital and business alliance with iLAC Co. Ltd. (headquartered in Tsukuba, Ibaraki; Taka-Aki Sato, President & CEO; hereinafter `iLAC`) which is developing a whole genome analysis business. Currently whole genome analysis is becoming increasingly important in precision medicine,*1 which uses analysis to select optimal medical treatments tailored to individual patients. Optimal preventive medical care is...